Risk of second cancer after ion beam radiotherapy: insights from animal carcinogenesis studies

References

• Alpen EL, Powers-Risius P, Curtis SB, DeGuzman R. 1993. Tumorigenic potential of high-Z, high-LET charged-particle radiations. Radiat Res. 136:382–391.
   PubMed Web of Science ®Google Scholar
• Ando K, Koike S, Oohira C, Ogiu T, Yatagai F. 2005. Tumor induction in mice locally irradiated with carbon ions: a retrospective analysis. J Radiat Res. 46:185–190.
   PubMed Web of Science ®Google Scholar
• Behjati S, Gundem G, Wedge DC, Roberts ND, Tarpey PS, Cooke SL, Van Loo P, Alexandrov LB, Ramakrishna M, Davies H. 2016. Mutational signatures of ionizing radiation in second malignancies. Nat Commun. 7:12605.
   PubMed Web of Science ®Google Scholar
• Berrington de Gonzalez A, Curtis RE, Kry SF, Gilbert E, Lamart S, Berg CD, Stovall M, Ron E. 2011. Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries. Lancet Oncol. 12:353–360.
   PubMed Web of Science ®Google Scholar
• Blyth BJ, Kakinuma S, Sunaoshi M, Amasaki Y, Hirano-Sakairi S, Ogawa K, Shirakami A, Shang Y, Tsuruoka C, Nishimura M, et al. 2015. Genetic analysis of T cell lymphomas in carbon ion-irradiated mice reveals frequent interstitial chromosome deletions: implications for second cancer induction in normal tissues during carbon ion radiotherapy. PLoS One. 10:e0130666.
   PubMed Web of Science ®Google Scholar
• Bouffler SD, Meijne EI, Huiskamp R, Cox R. 1996. Chromosomal abnormalities in neutron-induced acute myeloid leukemias in CBA/H mice. Radiat Res. 146:349–352.
   PubMed Web of Science ®Google Scholar
• Broeks A, Braaf LM, Wessels LF, van de Vijver M, De Bruin ML, Stovall M, Russell NS, van Leeuwen FE, Van 't Veer LJ. 2010. Radiation-associated breast tumors display a distinct gene expression profile. Int J Radiat Oncol Biol Phys. 76:540–547.
   PubMed Web of Science ®Google Scholar
• Brown N, Finnon R, Manning G, Bouffler S, Badie C. 2015. Influence of radiation quality on mouse chromosome 2 deletions in radiation-induced acute myeloid leukaemia. Mutat Res Genet Toxicol Environ Mutagen. 793:48–54.
   PubMed Web of Science ®Google Scholar
• Burns FJ, Strickland P, Vanderlaan M, Albert RE. 1978. Rat skin tumor incidence following single and fractionated exposures to proton radiation. Radiat Res. 74:152–158.
   PubMed Web of Science ®Google Scholar
• Casey HW, Prince JE, Hinkle DK, Caraway BL, Williams WT. 1968. Neoplastic skin response of rats after 13 MeV proton irradiation. Aerosp Med. 39:360–365.
   PubMedGoogle Scholar
• Chung CS, Yock TI, Nelson K, Xu Y, Keating NL, Tarbell NJ. 2013. Incidence of second malignancies among patients treated with proton versus photon radiation. Int J Radiat Oncol Biol Phys. 87:46–52.
   PubMed Web of Science ®Google Scholar
• Churchill ME, Gemmell MA, Woloschak GE. 1994. Detection of retinoblastoma gene deletions in spontaneous and radiation-induced mouse lung adenocarcinomas by polymerase chain reaction. Radiat Res. 137:310–316.
   PubMed Web of Science ®Google Scholar
• Clapp NK, Darden EB, Jr, Jernigan MC. 1974. Relative effects of whole-body sublethal doses of 60-MeV protons and 300-kVp X-rays on disease incidences in RF mice. Radiat Res. 57:158–186.
   PubMed Web of Science ®Google Scholar
• Covelli V, Di Majo V, Bassani B, Rebessi S, Coppola M, Silini G. 1984. Influence of age on life shortening and tumor induction after X-ray and neutron irradiation. Radiat Res. 100:348–364.
   PubMed Web of Science ®Google Scholar
• Dekkers F, Bijwaard H, Bouffler S, Ellender M, Huiskamp R, Kowalczuk C, Meijne E, Sutmuller M. 2011. A two-mutation model of radiation-induced acute myeloid leukemia using historical mouse data. Radiat Environ Biophys. 50:37–45.
   PubMed Web of Science ®Google Scholar
• Di Majo V, Coppola M, Rebessi S, Covelli V. 1990. Age-related susceptibility of mouse liver to induction of tumors by neutrons. Radiat Res. 124:227–234.
   PubMed Web of Science ®Google Scholar
• Dicello JF, Christian A, Cucinotta FA, Gridley DS, Kathirithamby R, Mann J, Markham AR, Moyers MF, Novak GR, Piantadosi S, et al. 2004. In vivo mammary tumourigenesis in the Sprague-Dawley rat and microdosimetric correlates. Phys Med Biol. 49:3817–3830.
   PubMed Web of Science ®Google Scholar
• Eley JG, Friedrich T, Homann KL, Howell RM, Scholz M, Durante M, Newhauser WD. 2016. Comparative risk predictions of second cancers after carbon-ion therapy versus proton therapy. Int J Radiat Oncol Biol Phys. 95:279–286.
   PubMed Web of Science ®Google Scholar
• Ellender M, Harrison JD, Meijne E, Huiskamp R, Kozlowski RE, Haines JW, Edwards AA, Ainsbury EA, Moody JC, Bouffler SD, et al. 2011. Intestinal tumours induced in Apc(Min/+) mice by X-rays and neutrons. Int J Radiat Biol. 87:385–399.
   PubMed Web of Science ®Google Scholar
• Friedman DL, Whitton J, Leisenring W, Mertens AC, Hammond S, Stovall M, Donaldson SS, Meadows AT, Robison LL, Neglia JP. 2010. Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst. 102:1083–1095.
   PubMedGoogle Scholar
• Gerweck LE, Huang P, Lu HM, Paganetti H, Zhou Y. 2014. Lifetime increased cancer risk in mice following exposure to clinical proton beam-generated neutrons. Int J Radiat Oncol Biol Phys. 89:161–166.
   PubMed Web of Science ®Google Scholar
• Greenberger BA, Pulsifer MB, Ebb DH, MacDonald SM, Jones RM, Butler WE, Huang MS, Marcus KJ, Oberg JA, Tarbell NJ, et al. 2014. Clinical outcomes and late endocrine, neurocognitive, and visual profiles of proton radiation for pediatric low-grade gliomas. Int J Radiat Oncol Biol Phys. 89:1060–1068.
   PubMed Web of Science ®Google Scholar
• Haines J, Bacher J, Coster M, Huiskamp R, Meijne E, Mancuso M, Pazzaglia S, Bouffler S. 2010. Microsatellite instability in radiation-induced murine tumours: influence of tumour type and radiation quality. Int J Radiat Biol. 86:555–568.
   PubMed Web of Science ®Google Scholar
• Hayata I, Ishihara T, Hirashima K, Sado T, Yamagiwa J. 1979. Partial deletion of chromosome No. 2 in myelocytic leukemias of irradiated C3H/He and RFM mice. J Natl Cancer Inst. 63:843–848.
   PubMedGoogle Scholar
• Heidenreich WF, Carnes BA, Paretzke HG. 2006. Lung cancer risk in mice: analysis of fractionation effects and neutron RBE with a biologically motivated model. Radiat Res. 166:794–801.
   PubMed Web of Science ®Google Scholar
• IARC. 2000. Ionizing radiation. Part 1: X- and gamma (γ)-radiation, and neutrons. Lyon: International Agency for Research on Cancer (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No 75.
   Google Scholar
• Ibrahim EM, Abouelkhair KM, Kazkaz GA, Elmasri OA, Al-Foheidi M. 2012. Risk of second breast cancer in female Hodgkin's lymphoma survivors: a meta-analysis. BMC Cancer. 12:197.
   PubMed Web of Science ®Google Scholar
• ICRP. 1991. 1990 Recommendations of the International Commission on Radiological Protection. Ann ICRP. 21:1–201.
   Google Scholar
• ICRP. 2003. Relative biological effectiveness (RBE), quality factor (Q), and radiation weighting factor (wR). International Commission on Radiation Protection (ICRP Publication 92). Ann ICRP. 33:1–117.
   Google Scholar
• ICRP. 2007. The 2007 Recommendations of the International Commission on Radiological Protection. ICRP publication 103. Ann ICRP. 37:1–332.
   Google Scholar
• Imaoka T, Nishimura M, Daino K, Hosoki A, Takabatake M, Kokubo T, Doi K, Showler K, Nishimura Y, Moriyama H, et al. 2017. Age modifies the effect of 2-MeV fast neutrons on rat mammary carcinogenesis. Radiat Res. 188:419–425.
   PubMed Web of Science ®Google Scholar
• Imaoka T, Nishimura M, Daino K, Kokubo T, Doi K, Iizuka D, Nishimura Y, Okutani T, Takabatake M, Kakinuma S, et al. 2013. Influence of age on the relative biological effectiveness of carbon ion radiation for induction of rat mammary carcinoma. Int J Radiat Oncol Biol Phys. 85:1134–1140.
   PubMed Web of Science ®Google Scholar
• Imaoka T, Nishimura M, Kakinuma S, Hatano Y, Ohmachi Y, Yoshinaga S, Kawano A, Maekawa A, Shimada Y. 2007. High relative biologic effectiveness of carbon ion radiation on induction of rat mammary carcinoma and its lack of H-ras and Tp53 mutations. Int J Radiat Oncol Biol Phys. 69:194–203.
   PubMed Web of Science ®Google Scholar
• Inaniwa T, Kanematsu N, Matsufuji N, Kanai T, Shirai T, Noda K, Tsuji H, Kamada T, Tsujii H. 2015. Reformulation of a clinical-dose system for carbon-ion radiotherapy treatment planning at the National Institute of Radiological Sciences, Japan. Phys Med Biol. 60:3271–3286.
   PubMed Web of Science ®Google Scholar
• Inskip PD, Ries LAG, Cohen RJ, Curtis RE. 2006. New malignancies following childhood cancer. In: Curtis RE, Freedman DM, Ron E, editors. New malignancies among cancer survivors: SEER cancer registries, 1973–2000. Bethesda (MD): NIH Pub. No. 05-5302. National Cancer Institute; p. 465–482.
   Google Scholar
• Kakinuma S, Kubo A, Amasaki Y, Nohima K, Imaoka T, Nishimura M, Shimada Y. 2004. Effect of carbon ions on life span shortening and tumorigenesis in mice. Biol Sci Space. 18:190.
   PubMedGoogle Scholar
• Kamada T, Tsujii H, Blakely EA, Debus J, De Neve W, Durante M, Jäkel O, Mayer R, Orecchia R, Pötter R, et al. 2015. Carbon ion radiotherapy in Japan: an assessment of 20 years of clinical experience. Lancet Oncol. 16:e93–e100.
   PubMed Web of Science ®Google Scholar
• Kanai T, Endo M, Minohara S, Miyahara N, Koyama-ito H, Tomura H, Matsufuji N, Futami Y, Fukumura A, Hiraoka T, et al. 1999. Biophysical characteristics of HIMAC clinical irradiation system for heavy-ion radiation therapy. Int J Radiat Oncol Biol Phys. 44:201–210.
   PubMed Web of Science ®Google Scholar
• Kellerer AM, Rossi HH. 1972. The theory of dual radiation action. In: Ebert M, Howard A, editors. Current topics in radiation research. Amsterdam: North-Holland Publishing; p. 85–158.
   Google Scholar
• Kominami R, Niwa O. 2006. Radiation carcinogenesis in mouse thymic lymphomas. Cancer Sci. 97:575–581.
   PubMed Web of Science ®Google Scholar
• La Tessa C, Berger T, Kaderka R, Schardt D, Burmeister S, Labrenz J, Reitz G, Durante M. 2014. Characterization of the secondary neutron field produced during treatment of an anthropomorphic phantom with x-rays, protons and carbon ions. Phys Med Biol. 59:2111–2125.
   PubMed Web of Science ®Google Scholar
• Ladra MM, Szymonifka JD, Mahajan A, Friedmann AM, Yong Yeap B, Goebel CP, MacDonald SM, Grosshans DR, Rodriguez-Galindo C, Marcus KJ, et al. 2014. Preliminary results of a phase II trial of proton radiotherapy for pediatric rhabdomyosarcoma. J Clin Oncol. 32:3762–3770.
   PubMed Web of Science ®Google Scholar
• Lippincott SW, Montour JL, Wilson JD, Rogers C, Bender R. 1972. Proton and alpha particle bombardment of mouse skin. Arch Pathol. 93:441–447.
   PubMedGoogle Scholar
• Macdonald SM, Sethi R, Lavally B, Yeap BY, Marcus KJ, Caruso P, Pulsifer M, Huang M, Ebb D, Tarbell NJ, et al. 2013. Proton radiotherapy for pediatric central nervous system ependymoma: clinical outcomes for 70 patients. Neuro-oncology. 15:1552–1559.
   PubMed Web of Science ®Google Scholar
• Maisin JR, Gerber GB, Vankerkom J, Wambersie A. 1996. Survival and diseases in C57BL mice exposed to X rays or 3.1 MeV neutrons at an age of 7 or 21 days. Radiat Res. 146:453–460.
   PubMed Web of Science ®Google Scholar
• Malumbres M, Perez de Castro I, Santos J, Melendez B, Mangues R, Serrano M, Pellicer A, Fernandez-Piqueras J. 1997. Inactivation of the cyclin-dependent kinase inhibitor p15INK4b by deletion and de novo methylation with independence of p16INK4a alterations in murine primary T-cell lymphomas. Oncogene 14:1361–1370.
   PubMed Web of Science ®Google Scholar
• Matsumoto S, Koba Y, Kohno R, Lee C, Bolch WE, Kai M. 2016. Secondary neutron doses to pediatric patients during intracranial proton therapy: Monte Carlo simulation of the neutron energy spectrum and its organ doses. Health Phys. 110:380–386.
   PubMed Web of Science ®Google Scholar
• Mizumoto M, Murayama S, Akimoto T, Demizu Y, Fukushima T, Ishida Y, Oshiro Y, Numajiri H, Fuji H, Okumura T, et al. 2017. Long-term follow-up after proton beam therapy for pediatric tumors: a Japanese national survey. Cancer Sci. 108:444–447.
   PubMed Web of Science ®Google Scholar
• Nakadai T, Nojima K, Kobayashi I, Sato K, Yasuda N, Mitani H, Hino O. 2004. HZE radiation effects for hereditary renal carcinomas. Biol Sci Space. 18:177–178.
   PubMedGoogle Scholar
• NCRP. 2012. Second primary cancers and cardiovascular disease after radiation therapy. Vol. 170. Bethesda: National Council on Radiation Protection and Measurements (NCRP Report).
   Google Scholar
• Newhauser WD, Durante M. 2011. Assessing the risk of second malignancies after modern radiotherapy. Nat Rev Cancer. 11:438–448.
   PubMed Web of Science ®Google Scholar
• Newhauser WD, Fontenot JD, Mahajan A, Kornguth D, Stovall M, Zheng Y, Taddei PJ, Mirkovic D, Mohan R, Cox JD, et al. 2009. The risk of developing a second cancer after receiving craniospinal proton irradiation. Phys Med Biol. 54:2277–2291.
   PubMed Web of Science ®Google Scholar
• Paunesku T, Zhang Y, Gemmell MA, Woloschak GE. 2000. p53 gene deletions in paraffin-preserved lymphoid tumors from irradiated mice. Leuk Res. 24:511–517.
   PubMed Web of Science ®Google Scholar
• Prince JE, Hinkle DK, Casey HW. 1969. Histologic changes in rat skin after 13 MeV proton irradiation. Aerosp Med. 40:504–508.
   PubMedGoogle Scholar
• Rithidech KN, Bond VP, Cronkite EP, Thompson MH. 1993. A specific chromosomal deletion in murine leukemic cells induced by radiation with different qualities. Exp Hematol. 21:427–431.
   PubMed Web of Science ®Google Scholar
• Rombi B, DeLaney TF, MacDonald SM, Huang MS, Ebb DH, Liebsch NJ, Raskin KA, Yeap BY, Marcus KJ, Tarbell NJ, et al. 2012. Proton radiotherapy for pediatric Ewing's sarcoma: initial clinical outcomes. Int J Radiat Oncol Biol Phys. 82:1142–1148.
   PubMed Web of Science ®Google Scholar
• Schippers JM, Lomax AJ. 2011. Emerging technologies in proton therapy. Acta Oncol. 50:838–850.
   PubMed Web of Science ®Google Scholar
• Sethi RV, Shih HA, Yeap BY, Mouw KW, Petersen R, Kim DY, Munzenrider JE, Grabowski E, Rodriguez-Galindo C, Yock TI, et al. 2014. Second nonocular tumors among survivors of retinoblastoma treated with contemporary photon and proton radiotherapy. Cancer. 120:126–133.
   PubMed Web of Science ®Google Scholar
• Shimada Y, Nishimura M, Kakinuma S, Okumoto M, Shiroishi T, Clifton KH, Wakana S. 2000. Radiation-associated loss of heterozygosity at the Znfn1a1 (Ikaros) locus on chromosome 11 in murine thymic lymphomas. Radiat Res. 154:293–300.
   PubMed Web of Science ®Google Scholar
• Sloan SR, Newcomb EW, Pellicer A. 1990. Neutron radiation can activate K-ras via a point mutation in codon 146 and induces a different spectrum of ras mutations than does gamma radiation. Mol Cell Biol. 10:405–408.
   PubMed Web of Science ®Google Scholar
• Stokkevåg CH, Fukahori M, Nomiya T, Matsufuji N, Engeseth GM, Hysing LB, Ytre-Hauge KS, Rorvik E, Szostak A, Muren LP. 2016. Modelling of organ-specific radiation-induced secondary cancer risks following particle therapy. Radiother Oncol. 120:300–306.
   PubMed Web of Science ®Google Scholar
• Suman S, Kumar S, Moon BH, Strawn SJ, Thakor H, Fan Z, Shay JW, Fornace AJ, Jr, Datta K. 2016. Relative biological effectiveness of energetic heavy ions for intestinal tumorigenesis shows male preponderance and radiation type and energy dependence in APC(1638N/+) mice. Int J Radiat Oncol Biol Phys. 95:131–138.
   PubMed Web of Science ®Google Scholar
• Sunaoshi M, Amasaki Y, Hirano-Sakairi S, Blyth BJ, Morioka T, Kaminishi M, Shang Y, Nishimura M, Shimada Y, Tachibana A, et al. 2015. The effect of age at exposure on the inactivating mechanisms and relative contributions of key tumor suppressor genes in radiation-induced mouse T-cell lymphomas. Mutat Res. 779:58–67.
   PubMed Web of Science ®Google Scholar
• Taddei PJ, Mahajan A, Mirkovic D, Zhang R, Giebeler A, Kornguth D, Harvey M, Woo S, Newhauser WD. 2010. Predicted risks of second malignant neoplasm incidence and mortality due to secondary neutrons in a girl and boy receiving proton craniospinal irradiation. Phys Med Biol. 55:7067–7080.
   PubMed Web of Science ®Google Scholar
• Travis LB, Demark Wahnefried W, Allan JM, Wood ME, Ng AK. 2013. Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors. Nat Rev Clin Oncol. 10:289–301.
   PubMed Web of Science ®Google Scholar
• Watanabe H, Ogiu T, Nishimura M, Masaoka Y, Kurosumi M, Takahashi T, Oguri T, Shoji S, Katoh O. 1998a. Comparison of tumorigenesis between accelerated heavy ion and X-ray in B6C3F1 mice. JRR. 39:93–100.
   PubMed Web of Science ®Google Scholar
• Watanabe H, Ogiu T, Nishizaki M, Fujimoto N, Kido S, Ishimura Y, Shiraki K, Kuramoto K, Hirata S, Shoji S, et al. 1998b. Induction of ovarian tumors by heavy ion irradiation in B6C3F1 mice. Oncol Rep. 5:1377–1380.
   PubMed Web of Science ®Google Scholar
• Weil MM, Ray FA, Genik PC, Yu Y, McCarthy M, Fallgren CM, Ullrich RL. 2014. Effects of 28Si ions, 56Fe ions, and protons on the induction of murine acute myeloid leukemia and hepatocellular carcinoma. PLoS One. 9:e104819.
   PubMed Web of Science ®Google Scholar
• Wood D, Cox A, Hardy K, Salmon Y, Trotter R. 1994. Head and neck tumors after energetic proton irradiation in rats. Adv Space Res. 14:681–684.
   PubMed Web of Science ®Google Scholar
• Yock TI, Caruso PA. 2012. Risk of second cancers after photon and proton radiotherapy: a review of the data. Health Phys. 103:577–585.
   PubMed Web of Science ®Google Scholar
• Yock TI, Yeap BY, Ebb DH, Weyman E, Eaton BR, Sherry NA, Jones RM, MacDonald SM, Pulsifer MB, Lavally B, et al. 2016. Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study. Lancet Oncol. 17:287–298.
   PubMed Web of Science ®Google Scholar
• Yonai S, Matsufuji N, Kanai T, Matsui Y, Matsushita K, Yamashita H, Numano M, Sakae T, Terunuma T, Nishio T, et al. 2008. Measurement of neutron ambient dose equivalent in passive carbon-ion and proton radiotherapies. Med Phys. 35:4782–4792.
   PubMed Web of Science ®Google Scholar
• Yonai S, Matsufuji N, Namba M. 2012. Calculation of out-of-field dose distribution in carbon-ion radiotherapy by Monte Carlo simulation. Med Phys. 39:5028–5039.
   PubMed Web of Science ®Google Scholar
• Yonekura Y, Tsujii H, Hopewell JW, Lopez PO, Cosset JM, Paganetti H, Montelius A, Schardt D, Jones B, Nakamura T. 2014. ICRP publication 127: radiological protection in ion beam radiotherapy. Ann ICRP. 43:5–113.
   PubMedGoogle Scholar
• Zhang Y, Woloschak GE. 1997. Rb and p53 gene deletions in lung adenocarcinomas from irradiated and control mice. Radiat Res. 148:81–89.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Woloschak GE. 1998. Detection of codon 12 point mutations of the K-ras gene from mouse lung adenocarcinoma by 'enriched' PCR. Int J Radiat Biol. 74:43–51.
   PubMed Web of Science ®Google Scholar